|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn268679675 |
003 |
OCoLC |
005 |
20231117015126.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
081103s1980 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d IDEBK
|d E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCA
|d OCLCF
|d YDXCP
|d OCLCQ
|d UAB
|d OCLCQ
|d LEAUB
|d OCLCO
|d OCLCQ
|d OCLCA
|d VLY
|d OCLCA
|d OCLCO
|d OCLCQ
|d INARC
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 646754944
|a 1162351594
|a 1397438472
|
020 |
|
|
|a 9780080581088
|q (electronic bk.)
|
020 |
|
|
|a 0080581080
|q (electronic bk.)
|
020 |
|
|
|a 0120329174
|q (electronic bk.)
|
020 |
|
|
|a 9780120329175
|q (electronic bk.)
|
020 |
|
|
|a 1281466565
|
020 |
|
|
|a 9781281466563
|
020 |
|
|
|a 9786611466565
|
020 |
|
|
|a 6611466568
|
035 |
|
|
|a (OCoLC)268679675
|z (OCoLC)646754944
|z (OCoLC)1162351594
|z (OCoLC)1397438472
|
050 |
|
4 |
|a RM300
|b .A38eb vol. 17
|
060 |
|
4 |
|a QV 5 A2442 v.17 1980
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.1
|2 22
|
245 |
0 |
0 |
|a Advances in pharmacology and chemotherapy.
|n Volume 17 /
|c edited by Silvio Garattini [and others] ; consulting editor, R.J. Schnitzer.
|
260 |
|
|
|a New York :
|b Academic Press,
|c 1980.
|
300 |
|
|
|a 1 online resource (x, 326 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in pharmacology and chemotherapy ;
|v v. 17
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Contents; Contributors to This Volumes; Chapter 1. Screening for and Evaluation of Anticoccidial Activity; I. Introduction; II. Screening in Embryos or Tissue Culture; III. Screening in the Chicken; IV. Cage Evaluation Experiments; V. Drug Resistance Studies; VI. Point and Type of Action Studies; VII. Conclusions; References; Chapter 2. Information Services of the International Cancer Research Data Bank (ICRDB) Program in Cancer Chemotherapy and Pharmacology; I. Introduction; II. Collection of Data; III. ICRDB Data Bases for Cancer Researchers
|
505 |
8 |
|
|a IV. Searching of Cancer Data Bases and Indexing of Biomedical InformationV. Publications Used to Disseminate Cancer-Related Information Automatically; VI. Scientist-to-Scientist Communication Projects; Reference; Chapter 3. Dihydrofolate Reductase: Binding of Substrates and Inhibitors and Catalytic Mechanism; I. Introduction; II. Critical Aspects of the Enzyme Structure; III. Physicochemical Aspects; IV. Biochemical Aspects; V. Folate Biochemistry; VI . Antifolate Pharmacology; References
|
505 |
8 |
|
|a Chapter 4. Distribution and Classification of Airway Histamine Receptors: The Physiological Significance of Histamine H2-ReceptorsI. Introduction; II. Airway Histamine Receptor Distribution and Classification; III. Mechanisms of Action of Histamine on Airway Smooth Muscles; IV. Modulatory Roles of Histamine H2-Receptors; V. Summary and Conclusions; References; Chapter 5. In Vitro Methods to Predict for Patient Response to Chemotherapy; I. Introduction; II. Requirements for in Vitro Systems; III. General Technical Problems for in Vitro Systems; IV. Specific in Vitro Predictive Tests
|
505 |
8 |
|
|a v. SummaryReferences; Chapter 6. Macrophage Activation for Nonspecific Tumor Cytotoxicity; I. Introduction; II. Pathways for Induction of Activated Macrophages; III. Mechanisms of the Cytotoxic Action of Activated Macrophages; IV. Naturally Occurring Inhibitors of Cytotoxic Activity; V. Therapeutic Considerations; VI. Concluding Remarks; References; Chapter 7. Prenatal and Neonatal Toxicology and Pathology of Heavy Metals; I. General Concept on Teratogenesis; II. Toxic Effects of Mercury on Development; III. Toxic Effects of Cadmium on Development; IV. Toxic Effects of Lead on Development
|
505 |
8 |
|
|a v. Concluding RemarksReferences; Chapter 8. Salicylates: Molecular Mechanism of Therapeutic Action; I. General Aspects; II. Special Aspects; III. General Summary and Conclusions; References; Chapter 9. Physiological and Pharmacological Determinants of Sensitivity and Resistance to 5-Fluorouracil in Lower Animals and Man; I. Introduction; II. Preclinical Studies; III. Clinical Studies; IV. Summary and Prospects; References; Index
|
520 |
|
|
|a ADV IN PHARMACOLOGY & CHEMOTHERAPY VOL 17.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Chemotherapy.
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
2 |
|a Drug Therapy
|0 (DNLM)D004358
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
6 |
|a Chimioth�erapie.
|0 (CaQQLa)201-0034750
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Chemotherapy
|2 fast
|0 (OCoLC)fst00853595
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a Garattini, Silvio.
|
700 |
1 |
|
|a Schnitzer, Robert J.
|q (Robert Julius),
|d 1894-
|
776 |
0 |
8 |
|i Print version:
|t Advances in pharmacology and chemotherapy. Volume 17.
|d New York : Academic Press, 1980
|z 9780120329175
|w (OCoLC)39619795
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120329175
|z Texto completo
|